Title:  Levamisole 
CAS Registry Number:  14769-73-4 
CAS Name:  (6S)-2,3,5,6-Tetrahydro-6-phenylimidazo[2,1-b]thiazole 
Additional Names:  (-)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole 
Trademarks:  Levovermax (Virbac);  Totalon (Mallinckrodt) 
Molecular Formula:  C11H12N2S 
Molecular Weight:  204.29 
Percent Composition:  C 64.67%, H 5.92%, N 13.71%, S 15.70% 
Literature References:  Biological response modifier with anthelmintic activity.  Prepn of racemate:  A. H. M. Raeymaekers et al., US 3274209 (1966 to Janssen); eidem, J. Med. Chem. 9, 545 (1966).  Pharmacology:  D. Thienpoint et al., Nature 209, 1084 (1966).  Prepn and abs config of isomers:  A. H. M. Raeymaekers et al., Tetrahedron Lett. 1967, 1467.  See also:  M. W. Bullock et al., J. Med. Chem. 11, 169 (1968); US 3565907 (1971 to Am. Cyanamid); Dewar et al., US 3579530 (1971 to ICI).  Stereospecific inhibition of succinic dehydrogenase:  H. Van den Bossche, P. A. J. Janssen, Biochem. Pharmacol. 18, 35 (1969).  Exptl effect on IL-1 production:  E. S. Kimball, Ann. N.Y. Acad. Sci. 685, 259 (1993).  Review of pharmacology:  H. Schneiden, Int. J. Immunopharmacol. 3, 9 (1981); of clinical use in parasitic infections:  M. J. Miller, Drugs 20, 122-130 (1980).  Determn in animal tissues by ELISA:  J. J. Silverlight, R. Jackman:  Analyst 119, 2705 (1994); by LC-MS:  A. Cannavan et al., ibid. 120, 331 (1995).  Clinical trial with fluorouracil in colon cancer:  C. G. Moertel et al., Ann. Intern. Med. 122, 321 (1995).  Review of immunopharmacology and clinical trials in cancer treatment:  H. C. Stevenson et al., J. Clin. Oncol. 9, 2052-2066 (1991); M. De Brabander et al., Anticancer Res. 12, 177-188 (1992); W. K. Amery, J. P. Bruynseels, Int. J. Immunopharmacol. 14, 481-486 (1992). 
Properties:  mp 60-61.5°.  [a]D25 -85.1° (c = 10 in chloroform). 
Melting point:  mp 60-61.5° 
Optical Rotation:  [a]D25 -85.1° (c = 10 in chloroform) 
  
Derivative Type:  Hydrochloride  
CAS Registry Number:  16595-80-5 
Manufacturers' Codes:  R-12564 
Trademarks:  Ascaridil (Cilag);  Decaris (Janssen);  Ergamisol (Janssen);  Levacide (Norbrook);  Levadin (Univet);  Levasole (Mallinckrodt);  Meglum (Bago);  Nemicide (Coopers);  Nilverm (Mallinckrodt);  Ripercol (Am. Cyanamid);  Solaskil (RPR);  Spartakon (Janssen);  Tramisol (Am. Cyanamid) 
Molecular Formula:  C11H12N2S.HCl 
Molecular Weight:  240.75 
Percent Composition:  C 54.88%, H 5.44%, N 11.64%, S 13.32%, Cl 14.73% 
Properties:  mp 227-229°.  [a]D20 -124 ± 2° (c = 0.9, water).  Sol in water.  Stable in aq acid media. 
Melting point:  mp 227-229° 
Optical Rotation:  [a]D20 -124 ± 2° (c = 0.9, water) 
  
Derivative Type:  DL-Form  
CAS Registry Number:  5036-02-2 
Additional Names:  Tetramisole;  tetramizole 
Properties:  Crystals, mp 87-89°. 
Melting point:  mp 87-89° 
  
Derivative Type:  DL-Form hydrochloride  
CAS Registry Number:  5086-74-8 
Manufacturers' Codes:  Bayer 9051;  McN-JR-8299;  R-8299 
Properties:  Crystals, mp 264-265°.  Sol in water (21 g/100 ml at 20°), methanol, propylene glycol; sparingly sol in ethanol.  Slightly sol in chloroform, hexane, acetone.  LD50 in mice, rats (mg/kg):  22, 24 i.v.; 84, 130 s.c.; 210, 480 orally (Thienpoint). 
Melting point:  mp 264-265° 
Toxicity data:  LD50 in mice, rats (mg/kg):  22, 24 i.v.; 84, 130 s.c.; 210, 480 orally (Thienpoint) 
  
Derivative Type:  D-(+)-Form  
Additional Names:  Dexamisole 
Properties:  mp 60-61.5°.  [a]D25 +85.1° (c = 10 in chloroform). 
Melting point:  mp 60-61.5° 
Optical Rotation:  [a]D25 +85.1° (c = 10 in chloroform) 
  
Derivative Type:  D-(+)-Form hydrochloride  
Manufacturers' Codes:  R-12563 
Properties:  mp 227-227.5°.  [a]D20 +125° (c = 0.7 in water). 
Melting point:  mp 227-227.5° 
Optical Rotation:  [a]D20 +125° (c = 0.7 in water) 
  
Therap-Cat:  Anthelmintic (nematodes); immunomodulator. 
Therap-Cat-Vet:  Anthelmintic (Nematodes). 
Keywords:  Anthelmintic (Nematodes); Immunomodulator.   |